Aceclidine+Brimonidine combination ophthalmic solution
22-150-0018
Phase 3 small_molecule completed
Quick answer
Aceclidine+Brimonidine combination ophthalmic solution for Presbyopia is a Phase 3 program (small_molecule) at LENZ Therapeutics with 6 ClinicalTrials.gov record(s).
Program details
- Company
- LENZ Therapeutics
- Indication
- Presbyopia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed